Company: GANX
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001558370-25-003823
Chunk: 37

Company: Gain Therapeutics, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 15
Chunk 37
---
.2​12/28/202110.5​Minoryx Agreement between Minoryx Therapeutics, S.L. and GT Gain Therapeutics SA.​S-1​333-253303​10.3​2/19/202110.6​Form of Exchange Agreement.​S-1​333-253303​10.10​2/19/202110.7​Form of Placement Agent Warrant.​S-1​333-253303​10.11​2/19/202110.8 +​Gain Therapeutics Inc. 2021 Inducement Equity Incentive Plan Restricted Stock Unit Award Agreement.​S-8​333-266142​4.5​7/15/202210.9+​Gain Therapeutics Inc. 2022 Equity Incentive Plan.​S-8​333-266142​4.6​7/15/202210.10+​Gain Therapeutics Inc. RSU Award Grant Notice and Award Agreement (2022 Equity Incentive Plan).​S-8​333-266142​4.7​7/15/202210.11+​Gain Therapeutics Inc. Stock Option Grant Notice and Award Agreement (2022 Equity Incentive Plan).​S-8​333-266142​4.8​7/15/202210.12​Form of Indemnification Agreement for Officers and Directors.​10-Q​001-40237​10.3​8/10/202310.13​Form of Indemnification Agreement for Officers and Directors.​10-Q​001-40237​10.3​11/14/202310.14​Form of Securities Purchase Agreement.​8-K​001-40237​10.1​11/22/202310.15+​Separation Agreement, by and between the Company and Matthias Alder, dated June 27, 2024.​10-Q​001-40237​10.2​11/14/202410.16​Distribution Agreement, by and between the Company and Oppenheimer & Co. Inc., dated September 6, 2024​8-K​001-40237​1.1​9/6/202410.17+​Amended and Restated Employment Agreement by and between the Company and Gene Mack, dated January 6, 2025.​8-K​001-40237